Pacira BioSciences, Inc.
American pharmaceutical company focused on non-opioid pain therapies including EXPAREL and ZILRETTA, being acquired by Viatris for $1.65 billion in a deal announced October 2026.
Company Type
public
Founded
2006
Headquarters
Brisbane, California, USA
Stock
Nasdaq: PCRX
Revenue
approximately $746 million (LTM to June 30, 2026)
Primary Market
United States
Shop Pacira BioSciences, Inc. Brands
Disclosure: We may earn commission from purchases
About Pacira BioSciences, Inc.
American pharmaceutical company focused on non-opioid pain therapies including EXPAREL and ZILRETTA, being acquired by Viatris for $1.65 billion in a deal announced October 2026.
Brands Owned by Pacira BioSciences, Inc.
Pacira BioSciences, Inc. owns 1 brand in our database. Explore the ownership tree below — click categories to expand and see individual brands.
Pacira BioSciences, Inc.
public · Founded 2006 · Brisbane, California, USA
1
brands
Stock Information
Sources & Further Reading
- [Pacira Official Website](
- Viatris press release: Viatris Agrees to Acquire Pacira BioSciences (October 8, 2026)
- SEC EDGAR: Pacira BioSciences, Inc. filings (tender offer commenced October 30, 2026)
- Bloomberg Law: Viatris to Buy Non-Opioid Drugmaker Pacira for $1.65 Billion (October 8, 2026)
Jobs at Pacira BioSciences, Inc.
Latest News About Pacira BioSciences, Inc.
Related Articles About Pacira BioSciences, Inc.
View more articles
Monthly IPO Roundup: November 2026 -- October's Biggest Listings
October 2026 IPOs: Jio Platforms set India's all-time record at $3.2B and surged 27%, GCash owner Mynt raised a Philippine-record P60.9B, Anthropic filed publicly for a possible mid-November debut, and U.S. listings were a biotech grab bag. Full recap.
Monthly M&A Roundup: October 2026 Brand Ownership Changes
October 2026's biggest deals: Paramount Skydance closed its $110B Warner Bros. Discovery takeover, Salesforce signed Braze for $5.66B, Proofpoint bought Varonis for $6.3B, the Weston family agreed to buy Boots for $8.9B, and Viatris added Pacira for $1.65B. Full breakdown.
Duracell vs Energizer: The Battery Brand Rivalry
Duracell is Berkshire Hathaway-owned (25-30% US share). Energizer is publicly traded (NYSE: ENR) with Rayovac. Together they control ~85% of branded US batteries, but Amazon Basics has 27.1% online. Explore our database.
Related Companies to Pacira BioSciences, Inc.
View more companies
Cardinal Health
American multinational healthcare services company specializing in pharmaceutical distribution, medical products, specialty pharmacy, and at-home healthcare solutions. One of the largest healthcare companies globally by revenue.
4 brands in portfolio
Cencora Inc.
American pharmaceutical distribution company and one of the largest healthcare companies globally by revenue, formerly known as AmerisourceBergen, with FY2025 revenue of $321.3 billion.
7 brands in portfolio
Centene Corporation
American multinational healthcare enterprise and the largest Medicaid managed care organization in the United States, providing managed care services and health insurance for government-sponsored healthcare programs, with FY2025 revenue of $194.8 billion.
6 brands in portfolio
CVS Health Corporation
American integrated healthcare company operating CVS Pharmacy, Aetna health insurance, CVS Caremark pharmacy benefits management, and MinuteClinic, publicly traded on the NYSE.
10 brands in portfolio
Elevance Health Inc.
American health benefits company providing medical, pharmacy, behavioral, and dental insurance products, formerly known as Anthem, headquartered in Indianapolis, Indiana.
4 brands in portfolio
HCA Healthcare, Inc.
Largest for-profit hospital operator in the United States, running 190 hospitals and roughly 2,500 ambulatory sites across 19 states and England, headquartered in Nashville, Tennessee.
3 brands in portfolio